来自专业的译者、企业、网页和免费的翻译库。
odmerek ceftazidima/avibaktama
dose of ceftazidime/avibactam
最后更新: 2017-04-26
使用频率: 1
质量:
spekter delovanja ceftazidima/avibaktama
spectrum of activity of ceftazidime/avibactam
最后更新: 2017-04-26
使用频率: 1
质量:
podatkov o študijah ceftazidima na živalih ni.
no data are available on animal studies with ceftazidime.
最后更新: 2017-04-26
使用频率: 1
质量:
približna koncentracija ceftazidima/avibaktama (mg/ml)
approximate ceftazidime/avibactam concentration (mg/ml)
最后更新: 2017-04-26
使用频率: 1
质量:
kloramfenikol je in vitro antagonist ceftazidima in drugih cefalosporinov.
chloramphenicol is antagonistic in vitro with ceftazidime and other cephalosporins.
最后更新: 2017-04-26
使用频率: 1
质量:
farmakokinetika ceftazidima pri bolnikih s hudo okvaro jeter ni ugotovljena.
the pharmacokinetics of ceftazidime in patients with severe hepatic impairment has not been established.
最后更新: 2017-04-26
使用频率: 1
质量:
koncentracijo ceftazidima v serumu je mogoče zmanjšati s hemodializo ali peritonealno dializo.
serum levels of ceftazidime can be reduced by haemodialysis or peritoneal dialysis.
最后更新: 2017-04-26
使用频率: 1
质量:
odstranjevanje ceftazidima in avibaktama je zmanjšano pri bolnikih z zmerno ali hudo okvaro ledvic.
elimination of ceftazidime and avibactam is decreased in patients with moderate or severe renal impairment.
最后更新: 2017-04-26
使用频率: 1
质量:
kombinacijo ceftazidima in avibaktama se sme med nosečnostjo uporabiti le, če morebitne koristi upravičujejo možno tveganje.
ceftazidime/avibactam should only be used during pregnancy if the potential benefit outweighs the possible risk.
最后更新: 2017-04-26
使用频率: 1
质量:
manj kot 1 % ceftazidima se izloči z žolčem in manj kot 0,25 % avibaktama se izloči v blatu.
less than 1% of ceftazidime is excreted via the bile and less than 0.25% of avibactam is excreted into faeces.
最后更新: 2017-04-26
使用频率: 1
质量:
vezava ceftazidima in avibaktama na človeške proteine je približno 10 % za ceftazidim in približno 8 % za avibaktam.
the human protein binding of both ceftazidime and avibactam is approximately 10% and 8%, respectively.
最后更新: 2017-04-26
使用频率: 1
质量:
ena viala vsebuje ceftazidim pentahidrat, ki ustreza 2 g ceftazidima, in natrijev avibaktamat, ki ustreza 0,5 g avibaktama.
each vial contains ceftazidime pentahydrate equivalent to 2 g ceftazidime and avibactam sodium equivalent to 0.5 g avibactam.
最后更新: 2017-04-26
使用频率: 1
质量:
blaga do zmerna okvara jeter ni vplivala na farmakokinetiko ceftazidima pri osebah, ki so 5 dni prejemale 2 g ceftazidima na 8 ur intravensko in niso imele okvarjenega delovanja ledvic.
mild to moderate hepatic impairment had no effect on the pharmacokinetics of ceftazidime in individuals administered 2 g intravenously every 8 hours for 5 days, provided renal function was not impaired.
最后更新: 2017-04-26
使用频率: 1
质量:
po pripravi vsebuje 1 ml raztopine 167,3 mg ceftazidima in 41,8 mg avibaktama (glejte poglavje 6.6).
after reconstitution, 1 ml of solution contains 167.3 mg of ceftazidime and 41.8 mg of avibactam (see section 6.6).
最后更新: 2017-04-26
使用频率: 1
质量:
po uporabi intravenskih bolusnih odmerkov 2 g ceftazidima na 12 ur pri bolnikih, starih 80 let ali več, je bil njegov povprečni eliminacijski razpolovni čas od 3,5 do 4 ure.
the mean elimination half-life of ceftazidime ranged from 3.5 to 4 hours following intravenous bolus dosing with 2 g every 12 hours in elderly patients aged 80 years or older.
最后更新: 2017-04-26
使用频率: 1
质量:
odločiti se je treba bodisi za prenehanje dojenja bodisi za prekinitev/prenehanje zdravljenja s kombinacijo ceftazidima in avibaktama, upoštevaje korist dojenja za otroka in korist zdravljenja za žensko.
a decision must be made whether to discontinue breast feeding or to discontinue/abstain from ceftazidime/avibactam therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman.
最后更新: 2017-04-26
使用频率: 1
质量:
Če bolnikom z okvaro ledvic niso zmanjšali odmerka ceftazidima, so med njegovo uporabo občasno poročali o nevroloških posledicah, med drugim o tremorju, mioklonusu, nekonvulzivnem epileptičnem statusu, konvulzijah, encefalopatiji in komi.
neurological sequelae, including tremor, myoclonus, non-convulsive status epilepticus, convulsion, encephalopathy and coma, have occasionally been reported with ceftazidime when the dose has not been reduced in patients with renal impairment.
最后更新: 2017-04-26
使用频率: 1
质量:
pri zdravih odraslih, ki so prejeli večkratne odmerke 2000 mg ceftazidima/500 mg avibaktama, infundirane v 2 urah vsakih 8 ur, sta bila njuna volumna porazdelitve v stanju dinamičnega ravnovesja približno 22 l (ceftazidim) in 18 l (avibaktam).
the steady-state volumes of distribution of ceftazidime and avibactam were about 22 l and 18 l, respectively in healthy adults following multiple doses of 2000 mg/500 mg ceftazidime/avibactam infused over 2 hours every 8 hours.
最后更新: 2017-04-26
使用频率: 1
质量: